Quick Answer
Alpha Tau Medical Ltd. reported Net Income of -$42.63 million for fiscal year 2025.
Alpha Tau Medical Ltd. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Net Income | -$42.63M -34.3% |
-$31.75M -8.9% |
-$29.16M +13.6% |
-$33.76M -23.8% |
-$27.27M -207.0% |
-$8.88M -6.2% |
| Diluted EPS | -$0.53 -17.8% |
-$0.45 -7.1% |
-$0.42 +20.8% |
-$0.53 +20.9% |
-$0.67 -204.5% |
-$0.22 +12.0% |
| Total Assets | $105.65M +22.6% |
$86.20M -19.7% |
$107.39M -10.6% |
$120.15M +184.6% |
$42.22M -20.3% |
$52.99M |
| Cash and Equivalents | $12.20M -11.1% |
$13.72M +8.4% |
$12.66M +116.9% |
$5.84M -74.9% |
$23.24M +49.0% |
$15.60M |
| Stockholders Equity | $77.10M +23.0% |
$62.67M -25.8% |
$84.47M -20.0% |
$105.66M +403.8% |
-$34.78M -312.6% |
-$8.43M -4267.4% |
| R&D Expense | $32.06M +18.7% |
$27.02M +2.3% |
$26.42M +26.5% |
$20.89M +82.5% |
$11.45M +51.7% |
$7.54M +13.7% |
| Operating Income | -$42.29M -17.3% |
-$36.04M -1.0% |
-$35.68M -11.0% |
-$32.14M -133.0% |
-$13.79M -49.2% |
-$9.24M -215.4% |
| Shares Outstanding | 88.01M +25.0% |
70.38M +1.0% |
69.67M +0.8% |
69.11M +70.5% |
40.53M +0.2% |
40.43M |
- Alpha Tau Medical Ltd. reported Net Income of -$42.63 million for fiscal year 2025.
- Alpha Tau Medical Ltd. showed a decrease of -34.3% in Net Income compared to the prior fiscal year.
- Alpha Tau Medical Ltd. reported Diluted EPS of $0.53 per share (loss) for fiscal year 2025.
- Alpha Tau Medical Ltd. showed a decrease of -17.8% in Diluted EPS compared to the prior fiscal year.
- Alpha Tau Medical Ltd. reported Total Assets of $105.65 million for fiscal year 2025.
- Alpha Tau Medical Ltd. showed an increase of +22.6% in Total Assets compared to the prior fiscal year.
- Alpha Tau Medical Ltd. reported Cash and Equivalents of $12.20 million for fiscal year 2025.
- Alpha Tau Medical Ltd. showed a decrease of -11.1% in Cash and Equivalents compared to the prior fiscal year.
- Alpha Tau Medical Ltd. reported Stockholders Equity of $77.10 million for fiscal year 2025.
- Alpha Tau Medical Ltd. showed an increase of +23.0% in Stockholders Equity compared to the prior fiscal year.
- Alpha Tau Medical Ltd. reported R&D Expense of $32.06 million for fiscal year 2025.
- Alpha Tau Medical Ltd. showed an increase of +18.7% in R&D Expense compared to the prior fiscal year.
- Alpha Tau Medical Ltd. reported Operating Income of -$42.29 million for fiscal year 2025.
- Alpha Tau Medical Ltd. showed a decrease of -17.3% in Operating Income compared to the prior fiscal year.
- Alpha Tau Medical Ltd. reported Shares Outstanding of 88.01 million shares for fiscal year 2025.
- Alpha Tau Medical Ltd. showed an increase of +25.0% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: